Literature DB >> 9708179

V beta 11+ T-lymphocyte expansion by toxic shock syndrome toxin-1 differs in mice bearing H-2q versus H-2b haplotypes.

Y X Zhao1, U Brunsberg, R Holmdahl, A Tarkowski.   

Abstract

We have recently demonstrated that toxic shock syndrome toxin-1 (TSST-1) expanded V beta 11+ T lymphocytes contribute to Staphylococcus aureus arthritis and sepsis-induced mortality. Interestingly, V beta 11+ T-cell mediated joint pathology varies in different mouse strains. In this study, we characterized the in vitro pattern of V beta 11+ T-cell expansion by TSST-1 in mice with various genetic backgrounds. Mice expressing major histocompatibility complex (MHC) class II I-E molecules did not expand V beta 11+ T cells upon stimulation with TSST-1. Using B10 congeneic I-E negative mouse strains, we found that the TSST-1-expanded V beta 11+ T cells in B10Q (H-2q) and B10M (H-2f) mice but not in B10B (H-2b) mice. Antigen-presenting cells (APC) from B10Q mice, L cells and lymphoma cell line transfected with a q gene did not restore the deficient V beta 11+ T-cell expansion by TSST-1 in purified T cells from B10B mice. In contrast, I-Ab APC were able to stimulate V beta 11+ T cells from H-2q mice. Furthermore, V beta 11+ T cells in H-2b mice did expand when exposed to staphylococcal enterotoxin A (SEA). These findings suggest that the T-cell repertoire, skewed by clonal deletion and inactivation of self-reactive T cells, accounts for the different magnitude of V beta 11+ T-cell expansion among the different mouse strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708179      PMCID: PMC1364323          DOI: 10.1046/j.1365-2567.1998.00484.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

Review 1.  T-cell reactivity and tolerance to Mlsa-encoded antigens.

Authors:  H R MacDonald; A L Glasebrook; R Schneider; R K Lees; H Pircher; T Pedrazzini; O Kanagawa; J F Nicolas; R C Howe; R M Zinkernagel
Journal:  Immunol Rev       Date:  1989-02       Impact factor: 12.988

2.  Stimulation of all T cells bearing V beta 1, V beta 3, V beta 11 and V beta 12 by staphylococcal enterotoxin A.

Authors:  H Takimoto; Y Yoshikai; K Kishihara; G Matsuzaki; H Kuga; T Otani; K Nomoto
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

3.  Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.

Authors:  T Uchiyama; T Tadakuma; K Imanishi; M Araake; S Saito; X J Yan; H Fujikawa; H Igarashi; N Yamaura
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

4.  Toxin involvement in toxic shock syndrome.

Authors:  B A Crass; M S Bergdoll
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

Review 5.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

6.  Major histocompatibility complex class II region confers susceptibility to Staphylococcus aureus arthritis.

Authors:  A Abdelnour; Y X Zhao; R Holmdahl; A Tarkowski
Journal:  Scand J Immunol       Date:  1997-03       Impact factor: 3.487

7.  Thymic requirement for clonal deletion during T cell development.

Authors:  A M Fry; L A Jones; A M Kruisbeek; L A Matis
Journal:  Science       Date:  1989-11-24       Impact factor: 47.728

8.  HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.

Authors:  A Herman; G Croteau; R P Sekaly; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

9.  The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells.

Authors:  J Bill; O Kanagawa; D L Woodland; E Palmer
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

10.  The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells.

Authors:  P Marrack; M Blackman; E Kushnir; J Kappler
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.